澳大利亚细胞和基因治疗（CAGT）产品的临床开发

CTN: Clinical Trial Notification, IND: Investigational New Drug, IB: Investigator Brochure, PICF: Participant Information and Consent Form, IBC: Institutional Biosafety Committee, FDA: Food and Drug Administration, EMA: European Medicines Agency, KOL: Key Opinion Leader Insight Brief Clinical Development of Cell and Gene Therapy (CAGT) Products in Australia Table of contents | Why Australia for CAGT trials? | 1 | | --- | --- | | Mature R&D ecosystem | 2 | | Established and favorable regulatory pathway in Au ...